TXMD
TherapeuticsMD, Inc.
Key Financials
Operating Income
$-4390000
↑ 7.8%
Net Income
$-569000
↑ 73.9%
Revenue
$1.8M
↑ 35.3%
EPS (Diluted)
$-0.05
↑ 73.7%
Total Liabilities
$10.8M
↓ 5.9%
Gross Profit
$1.3M
↓ 98.1%
Total Assets
$37.7M
↓ 3.0%
Shareholders' Equity
$26.9M
↓ 1.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TXMD |
| Company Name | TherapeuticsMD, Inc. |
| CIK | 25743 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 561-961-1900 |